Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Kalopanax Saponin B
2. Kalopanaxsaponin B
3. Kizuta Saponin K(12)
4. Kizuta Saponin K12
1. 14216-03-6
2. Kalopanaxsaponin B
3. Akeboside Sth
4. Hederoside H1
5. Tauroside H2
6. Glycoside L-h2
7. Pericarsaponin Pk
8. Tauroside St-h2
9. Akebia Saponin Pk
10. Pulsatilla Saponin F
11. Hederasaponin C
12. Chebi:69371
13. 2608b2l1bq
14. Olean-12-en-28-oic Acid, 3- ((2-o-(6-deoxy-alpha-l-mannopyranosyl)-alpha-l-arabinopyranosyl)oxy)-23-hydroxy-, O-6-deoxy-alpha-l-mannopyranosyl-(1-4)-o-beta-d-glucopyranosyl-(1-6)-beta-d-glucopyranosyl Ester, (3beta,4alpha)-
15. Hederacol
16. Unii-2608b2l1bq
17. Akebiasaponin Pk
18. Hederacaucaside D
19. Astrantiasaponin H
20. Pulsatillasaponin F
21. Kalopanax Saponin B
22. Einecs 238-072-2
23. Pericarpsasaponin Pk
24. Pulsatillasaponin Ii
25. Kizuta Saponin K(12)
26. Hederacoside C With Hplc
27. Schembl2997243
28. Chembl1910840
29. Dtxsid701317445
30. Hy-n0253
31. Mfcd00198062
32. Akos037514687
33. Ccg-270660
34. Cs-5691
35. Ac-34096
36. N2013
37. S3919
38. Q27137710
39. 6-deoxy-alpha-l-mannopyranosyl-(1->4)-beta-d-glucopyranosyl-(1->6)-1-o-[(3beta)-3-{[2-o-(6-deoxy-alpha-l-mannopyranosyl)-alpha-l-arabinopyranosyl]oxy}-23-hydroxy-28-oxoolean-12-en-28-yl]-beta-d-glucopyranose
40. Hederagenin 3-o-alpha-l-rhamnopyranosyl-(1->2)-o-alpha-l-arabinopyranoside 28-o-alpha-l-rhamnopyranosyl-(1->4)-o-beta-d-glucopyranosyl-(1->6)-o-beta-d-glucopyranosyl Ester
41. Olean-12-en-28-oic Acid, 3- ((2-o-(6-deoxy-.alpha.-l-mannopyranosyl)- .alpha.-l-arabinopyranosyl)oxy)-23-hydroxy-, O-6-deoxy-.alpha.-l- Mannopyranosyl-(1-4)-o-.beta.-d-glucopyranosyl-(1-6)-.beta.-d- Glucopyranosyl Ester, (3.beta.,4.alpha.)-
42. Olean-12-en-28-oic Acid, 3-((2-o-(6-deoxy-alpha-l-mannopyranosyl)-alpha-l-arabinopyranosyl)oxy)-23-hydroxy-, O-6-deoxy-alpha-l-mannopyranosyl-(1.4)-o-beta-d-glucopyranosyl-(1.6)-beta-d-glucopyranosyl Ester, (3beta,4alpha)-
| Molecular Weight | 1221.4 g/mol |
|---|---|
| Molecular Formula | C59H96O26 |
| XLogP3 | -2 |
| Hydrogen Bond Donor Count | 15 |
| Hydrogen Bond Acceptor Count | 26 |
| Rotatable Bond Count | 14 |
| Exact Mass | 1220.61898316 g/mol |
| Monoisotopic Mass | 1220.61898316 g/mol |
| Topological Polar Surface Area | 413 Ų |
| Heavy Atom Count | 85 |
| Formal Charge | 0 |
| Complexity | 2370 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 33 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
33
PharmaCompass offers a list of Hederacoside C API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hederacoside C manufacturer or Hederacoside C supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hederacoside C manufacturer or Hederacoside C supplier.
PharmaCompass also assists you with knowing the Hederacoside C API Price utilized in the formulation of products. Hederacoside C API Price is not always fixed or binding as the Hederacoside C Price is obtained through a variety of data sources. The Hederacoside C Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hederacoside C manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hederacoside C, including repackagers and relabelers. The FDA regulates Hederacoside C manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hederacoside C API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Hederacoside C supplier is an individual or a company that provides Hederacoside C active pharmaceutical ingredient (API) or Hederacoside C finished formulations upon request. The Hederacoside C suppliers may include Hederacoside C API manufacturers, exporters, distributors and traders.
Hederacoside C Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hederacoside C GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hederacoside C GMP manufacturer or Hederacoside C GMP API supplier for your needs.
A Hederacoside C CoA (Certificate of Analysis) is a formal document that attests to Hederacoside C's compliance with Hederacoside C specifications and serves as a tool for batch-level quality control.
Hederacoside C CoA mostly includes findings from lab analyses of a specific batch. For each Hederacoside C CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hederacoside C may be tested according to a variety of international standards, such as European Pharmacopoeia (Hederacoside C EP), Hederacoside C JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hederacoside C USP).
